At CPhI North America 2017, the US Pharmacopeial Convention will be discussing its upcoming revision and modernization of the standards for elemental and organic impurities. / read more /
UC Berkeley appealed the February 2017 decision that determined Harvard and MIT's Broad Institute and Berkeley's CRISPR-Cas9 technologies were separately patentable. / read more /
Standard Homeopathic Company is recalling all lots of Hyland's Baby Teething Tablets and Hyland's Nighttime Baby Teething Tablets due to inconsistent amounts of belladonna alkaloids. / read more /
The funding allows the company to broaden its range of services and finance its move to new laboratory facilities in the Illkirch-Graffenstaden innovation park in northeast France. / read more /
The transfer of fluids is governed by different equipment requirements across the medical, biopharma, and cell therapy manufacturing industries. / read more /
The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories. / read more /
eDose Counter for MDIs
Aptar Pharma unveils its eDose Counter for metered dose inhalers (MDIs). Our patented eDose Counter for MDIs is designed to be easy-to-use and reliable, and contributes to patient compliance. / Read more/
Vcaps® Enteric Encapsulation Technology
Vcaps® Enteric Capsule is a fully compliant capsule technology that simplifies drug enteric delivery implementation from early-stage development to commercial manufacturing. / Read more/
Manufacturing and Formulation Solutions for Inhaled Dose Forms
Catalent combines its formulation expertise, manufacturing excellence and particle size reduction technologies to provide a broad range of solutions in the development of inhalation and nasal drug products. / Read more/
A compilation of articles in a three-handbook set covering general Analytical Testing and Stability in the manufacture, packaging, storing, and testing of formulated products. / Click here /
Quality issues can appear at any stage of the bio/pharmaceutical development and manufacturing supply chain. Drug companies must monitor raw materials, suppliers, contract service providers, facilities, manufacturing processes, and production workers. In this e-book, the editors examine current quality issues, and how the industry is addressing quality challenges throughout the supply chain.
